PA I admire your spirit in BTA. I still have mine but unlike SRX they haven't made me any money so that clouds my judgment (even though I know it shouldn't). Like Muzza says let the share price do the talking. Agree with your comments on SRX and I guess the research and clinical trial spend will be higher given the number of large trials going on but I'm hoping the market already knows all of this. I wouldn't think Perpetual hadn't already factored this in when they took some of Dr Gray's holdings at $5.40 and then again at $5.15 to become a substantial holder.
Massive upside potential on SRX if the trial results keep giving support. I like what bilbar said "I intend to continue to invest until their product becomes redundant or Cancer is cured - which is a long time from now," which sums up my thinking here too.
I guess my concern having watched CXS get taken over and CST likely to go too, is if the trial results do come up trumps we'll get some low ball offer that takes away all that potential from the current SH's and gives it to another group for a lousy 40, 50 or 60% premium.
Time will tell.
SRX Price at posting:
$5.04 Sentiment: LT Buy Disclosure: Held
